z-logo
Premium
Proliferation index as a prognostic marker in hemangiopericytoma of the head and neck
Author(s) -
Kowalski Paul J.,
Paulino Augusto F. G.
Publication year - 2001
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.1065
Subject(s) - mitotic index , hemangiopericytoma , pleomorphism (cytology) , head and neck , proliferation index , pathology , proliferative index , proliferation marker , medicine , immunoperoxidase , stain , biology , immunohistochemistry , staining , mitosis , surgery , immunology , antibody , monoclonal antibody , microbiology and biotechnology
Background Hemangiopericytoma (HPC) of the head and neck is a rare neoplasm whose biologic behavior is difficult to predict by means of conventional histologic parameters. Methods H & E–stained sections from 12 cases of HPC were reviewed. Proliferation index was assessed using an immunoperoxidase stain for MIB‐1 (Ki‐67). Results The study group consisted of 4 adult men, 5 adult women, and 1 infant male. Necrosis, hypercellularity, and pleomorphism were found in 1, 5, and 6 case(s), respectively. The mitotic index per 10 high power fields varied from 0‐1 to 15. Proliferation indices using MIB‐1 ranged from 2.6% to 52.5%. Clinical follow‐up revealed 3 cases with recurrence all possessing proliferation indices of approximately 10%. Conclusions Standard histomorphologic features may be inadequate predictors of clinical outcome. A proliferation index of 10% or greater may indicate a more aggressive subset of HPC of the head and neck. © 2001 John Wiley & Sons, Inc. Head Neck 23: 492–496, 2001.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom